The cannabis industry continues to spend millions of dollars on high-powered lobbyists to sway U.S. senators to pass marijuana reform, but those efforts could be thwarted...
Canada’s federal government accounts for a growing share of the unpaid debts racked up by failed cannabis companies, lending credence to claims the nation’s nascent adult-use...
After first unveiling a blueprint for recreational cannabis legalization in October 2022, Germany’s draft framework was then sent to the European Commission – the EU’s executive...
Toronto-headquartered Avicanna announced the closing of its acquisition of the Medical Cannabis by Shopper’s Business unit from major Canadian pharmacy chain Shoppers Drug Mart. The price tag was 2.6...
Montreal cannabis producer Cannara Biotech reported a profit of 2.9 million Canadian dollars ($2.2 million) in its third quarter that ended in May, according to its recently released...
Canada’s federal government could face legal consequences for failing to facilitate research on potential health issues experienced by cannabis smokers, according to the former chair of the task...
Canada’s federal government could face legal consequences for failing to facilitate research on potential health issues experienced by cannabis smokers, according to the former chair of the task...
Are medical and adult-use cannabis effectively the same thing, and can businesses thrive in both markets? Some executives and regulators will tell you there is no real difference,...
In the face of slumping marijuana stock prices, publicly traded Canadian cannabis producers and U.S. ancillary companies are increasingly turning to share consolidations to maintain their...
Auxly Cannabis Group and British tobacco giant Imperial Brands agreed to extend by 24 months the maturity date of a debenture worth 123 million Canadian dollars ($94 million),...